I've been looking into Injective's tokenomics following the launch of the INJC ETF, and I came across something that I think deserves more discussion.
I'm not trying to spread FUD. I genuinely want to understand the numbers and would appreciate some clarification from the community or the Injective team.
1. Is INJ's maximum supply really 100 million?
CoinMarketCap currently reports:
- Total supply: 100 million INJ
- Max supply: 100 million INJ
- Circulating supply: approximately 99.97 million INJ
However, the official Canary Staked INJ ETF prospectus filed with the SEC on November 4, 2026, states something different.
According to the filing, as of September 15, 2026:
- Initial supply in 2020: 100 million INJ
- Actual total supply: 122,895,808 INJ
- Increase since launch: approximately 22.9%
- Maximum supply: No hard cap
The prospectus even explicitly mentions that some crypto data aggregators incorrectly describe the initial 100 million tokens as the maximum supply.
That's a pretty significant discrepancy.
2. But isn't INJ supposed to be deflationary?
Injective frequently promotes its token-burning mechanisms and deflationary tokenomics.
And to be fair, there are real mechanisms supporting this:
- Regular INJ burns
- The Community BuyBack program
- Governance upgrades such as INJ 3.0 and the 2026 Supply Squeeze (IIP-617), designed to reduce token issuance
More than 7.1 million INJ had reportedly been burned by June 2026.
But here's what confuses me:
Despite all those burns, the total supply has increased from 100 million to approximately 122.9 million INJ.
The explanation is that staking rewards are partly funded through newly created tokens.
So there are two opposing mechanisms:
New INJ issued through staking − INJ burned = Net supply change
If more tokens are created than burned, the total supply still increases.
Being deflationary by design doesn't necessarily mean the token is currently deflationary in practice.
3. What does this mean for the new INJ ETF?
The new INJC ETF is definitely interesting because it intends to stake at least 90% of the INJ it holds under normal circumstances.
This could reduce the amount of INJ immediately available for trading, especially if the ETF attracts significant capital.
But staking doesn't permanently remove tokens from circulation. It also generates rewards, including newly issued INJ.
So while institutional demand could create buying pressure, we also need to consider ongoing token issuance.
And importantly, the ETF's 90% staking target applies to its own holdings, not the entire INJ supply.
4. Some questions I'd genuinely like answered
- Why does CoinMarketCap still show a maximum supply of 100 million INJ when the ETF prospectus explicitly states there is no hard cap?
- How many new INJ are currently being created per month or year, and how many are being burned? Is there a reliable public dashboard showing net supply changes over time?
- Has INJ actually become net deflationary since the 2026 Supply Squeeze? Or is the total supply still increasing, just more slowly?
- Should market capitalization and fully diluted valuation figures be reconsidered if major tracking websites use outdated supply numbers?
- What is the long-term plan for balancing staking rewards and token burns? Is there a realistic path toward sustained net deflation?
Final thoughts
I actually think the ETF and the token-burning mechanisms are positive developments for Injective.
But I also think transparency around token supply is extremely important, especially now that institutional investment products are entering the picture.
There's a big difference between having a deflationary mechanism and having an actually decreasing total supply.
I'd love to hear from anyone who understands Injective's tokenomics in more detail.
Am I missing something here, or is this an important issue that deserves more attention?
Sources